Stocktoria

Erasca, Inc. ERAS

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-07-15

Erasca, Inc. statistics & valuation

Market cap$5.0B
P / B15.3×
Return on equity-38.3%
Return on capital-38.3%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-26.90% -59.00% -39.50% -38.20% -38.30% 202020212022202320242025
Shares outstanding
21.9M 119.1M 149.3M 151.1M 283.2M 284.2M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-81.40% -24.50% -47.20% -31.60% -32.20% -31.40% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$1.85 -$1.99 -$0.83 -$0.69 -$0.44 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-31.4%-32.2%-31.6%-47.2%-24.5%-81.4%
Return on equity-38.3%-38.2%-39.5%-59.0%-26.9%89.2%
Current ratio10.049.8412.269.1316.028.77

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.